69É«ÇéƬ

69É«ÇéƬ's Dr. Sheetal Salgaonkar, Vice President and Medical Director, Global Medical, 69É«ÇéƬ India, offers a fascinating case study on serum protein tests and how they should be considered in risk assessment. Read More

Insurance-linked wellness programs, which for years have shown more promise than sustainable results, now appear poised for widespread implementation and impact. In working with clients around the world, 69É«ÇéƬ has developed wellness-related insights in four key areas&n...

Read More

Is hindsight 2021? 69É«ÇéƬ's Ron Herrmann shares lessons learned from a turbulent year and looks forward to a bright future.

Read More

When it comes to marketing life insurance, a new study from 69É«ÇéƬ suggests timing may be everything. 69É«ÇéƬ's behavioral science team conducted an experiment based on a neuroscience testing technique called Implicit Reaction Time to explore how best to predict when consumers... Read More

Read a case study on serum protein tests, explore climate change’s impact on health and more. 

Read More

Individuals who have only low-severity medications in their prescription histories may not necessarily be those with the least mortality risk. In On the Risk, 69É«ÇéƬ's experts discuss the ways mortality risk of those with less robust histories and no high-sever...

Read More

By the year 2060, almost 24% of the US population will be age 65 or older. Biomedical and public health advances have led to great increases in longevity and a shift in disease burden to multiple chronic diseases with aging. In On the Risk, 69É«ÇéƬ's experts discus... Read More

Bancassurers are at a crossroads. Amid rapid evolution in customer expectations, business models and technology, banks and insurers must determine how best to take advantage of change. 69É«ÇéƬ's Othmane Akesbi surveys the landscape and shares seven trends to watch. Read More

To prepare for the implementation of IFRS 17, 69É«ÇéƬ has met with life and health insurers around the globe over the past several years. 69É«ÇéƬ's Paul Sauvé shares common themes and insights 69É«ÇéƬ has discovered in this process.

Read More

Continuous glucose monitoring (CGM) allows for real-time measurement of blood glucose, and is a technology being used by an estimated 7 million individuals in the U.S. and growing. In On the Risk, 69É«ÇéƬ's Drs. Dave Rengachary and Lauren Garfield explore t...

Read More

A harrowing bout with a breakthrough case of COVID-19 causes 69É«ÇéƬ's Jennifer Johnson to have a breakthrough of a different kind. She shares her wrenching personal experience, offers some lessons learned, and embarks on a conversation with 69É«ÇéƬ's physicians about the parti... Read More

69É«ÇéƬ has launched a Data and Analytics Ethical Framework, a set of enterprise-wide guiding principles for data utilization. 69É«ÇéƬ's Doug Knowling  explains...

Read More

In , Greig Woodring, retired president and CEO of 69É«ÇéƬ and the International Insurance Society’s 2021 Insurance Hall of Fame inductee, shares his unique... Read More

Read More

Read More

Customers increasingly demand a seamless, non-intrusive, insurance purchasing experience. Multivariate technologies can empower life and health carriers to deliver. 

Curious? Ask AURA.

Read More

The insurance industry is built on trust. The pandemic and its fallout, along with the emergence of a more digital society, threaten to erode that trust. Actuaries must continue to develop behaviours and tools that make instilling trust a primary focus moving forward. Read More

Curious about 69É«ÇéƬ's medical insights?  Contact us to learn m...

Read More

To increase understanding of the ever-evolving condition that is known as “long COVID," 69É«ÇéƬ has launched a  t...

Read More

The 69É«ÇéƬ India office was delighted to host over 380 clients at our two-day virtual RACE (69É«ÇéƬ Academy of Continued Education) webinar series. Conducted annually (but cancelled last year due to the pandemic), the event featured multiple in-depth presentations o...

Read More